To demonstrate specificity for tumor antigens we included control groups of T cells transduced either with tumor-irrelevant CAR genes (P28z, targeting the Prostate-Specific Membrane Antigen21), or TCR genes (MSLN-TCR, specific for Mesothelin22). This evidence concerns the gene MSLN and neoplasm.